Revenue and Segment Disclosures - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Feb. 28, 2026 |
Feb. 28, 2025 |
Feb. 29, 2024 |
|||
| Segment Reporting [Line Items] | |||||
| Gross Profit | $ 418.2 | $ 394.9 | $ 490.7 | ||
| Cost of Revenue | 130.9 | 140.0 | 268.4 | ||
| Restructuring Charges | 15.7 | 26.1 | 37.3 | ||
| Research and development | 113.6 | 108.8 | 127.1 | ||
| Sales and marketing | 114.0 | 95.5 | 104.0 | ||
| General and administrative | 128.8 | 159.7 | 187.2 | ||
| Amortization | 11.4 | 17.7 | 26.7 | ||
| Goodwill impairment loss continuing operations | 15.9 | ||||
| Impairment of long-lived assets (note 4) | 2.1 | 9.6 | 15.3 | ||
| Prior Debentures fair value adjustment | 0.0 | 0.0 | 3.5 | ||
| Litigation settlement | 0.0 | 2.8 | 0.0 | ||
| Investment income, net | (10.7) | (7.7) | (18.8) | ||
| Income before income tax | 59.0 | 8.5 | 29.8 | ||
| Revenues | 549.1 | 534.9 | 759.1 | ||
| Operating Segments | |||||
| Segment Reporting [Line Items] | |||||
| Segment gross margin | 420.4 | 397.3 | 493.7 | ||
| Revenues | 549.1 | 534.9 | 759.1 | ||
| Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment | |||||
| Segment Reporting [Line Items] | |||||
| Segment Reporting, Reconciling Item, Stock Compensation | [1] | 2.2 | 2.4 | 3.0 | |
| Investment income, net | $ 10.7 | $ 7.7 | $ 18.8 | ||
| |||||
| X | ||||||||||
- Definition Goodwill impairment loss continuing operations No definition available.
|
| X | ||||||||||
- Definition Segment gross margin No definition available.
|
| X | ||||||||||
- Definition Segment Reporting, Reconciling Item, Stock Compensation No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss for long-lived asset held and used. Includes, but is not limited to, impairment loss for long-lived asset to be disposed of other than by sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|